Sec Form 4 Filing - Vazquez Adrian @ Apollo Medical Holdings, Inc. - 2018-08-24

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Vazquez Adrian 2. Issuer Name and Ticker or Trading Symbol Apollo Medical Holdings, Inc. [ AMEH] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Co-Chief Medical Officer (Last) (First) (Middle) 700 N. BRAND BLVD., SUITE 1400 3. Date of Earliest Transaction (MM/DD/YY) 08/24/2018 (Street) GLENDALE, CA91203 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 08/24/2018 M 30,000 A $ 1.5 942,338 D Common Stock 08/24/2018 M 10,000 A $ 10 952,338 D Common Stock 08/24/2018 M 18,574 A $ 6.37 970,912 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (right to buy) $ 1.5 08/24/2018 M 30,000 12/09/2010( 1 ) 12/08/2020 Common Stock 30,000 $ 0 33,400 D Stock Option (right to buy) $ 10 08/24/2018 M 10,000 07/10/2014( 2 ) 07/10/2024 Common Stock 10,000 $ 0 23,400 D Stock Option (right to buy) $ 6.37 08/24/2018 M 18,574 09/14/2016( 3 ) 02/14/2021 Common Stock 18,574 $ 0 4,826 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Vazquez Adrian 700 N. BRAND BLVD. SUITE 1400 GLENDALE, CA91203 Co-Chief Medical Officer Signatures Adrian Vazquez 08/28/2018 Signature of Reporting Person Date

Explanation of Responses:

( 1 )One third (1/3) of the shares subject to the option vested on December 9, 2010, December 9, 2011 and December 9, 2012, respectively. ( 2 )One thirty-sixth (1/36) of the shares subject to the option vested on July 10, 2014 and on each monthly anniversary of July 10, 2014, respectively. ( 3 )The option was approved by the Issuer's Compensation Committee on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's stockholders approved the plan on September 14, 2016. The option vested as to 15,584 shares on February 15, 2016 and the balance of the shares subject to the option vested at a rate of approximately 651 shares per month commencing on March 15, 2016.

Remarks: The acquisition of the Issuer's common stock reported on this Form 4 resulted from the exercise of options granted by the Issuer's Compensation Committee, a committee solely composed of two or more non-employee directors, and is therefore exempt from section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to rule 16b-3(d)(1) thereunder.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.